Silver Book Fact

“Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant was not an option. Survival statistics for patients with Sherrie’s condition are grim. Even with the best treatment available, only 50 percent of heart failure patients live beyond a year.
Her doctor suggested that Sherri enroll in a clinical trial. Sherri soon became a patient and a member of the group that received an implantable heart pump.
The results were immediate. Four days after receiving her heart pump Sherri was back on her feet. ‘I could not believe it. The pump had given me back my life,’ she said. ‘Without this procedure, I would not have lived to see my youngest grandson who is now two and a half years old.’ Sherri is now back in South Carolina with her heart pump and her five grand-children, who prefer that she stay right where she is.”

Investment in Research Saves Lives and Money. http://www.researchamerica.org/advocacy/investment.html. Published 2005

Reference

Title
Investment in Research Saves Lives and Money
Publisher
Research!America
Publication Date
Published 2005
Authors
Research!America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.  
  • Pioglitazone associated with relative risk reduction in recurrent stroke
    The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative…  
  • About 70% of the survival improvement in heart attack mortality resulted from changes in technology.  
  • Use of antihypertensive therapies avoided an estimated $10.7 billion in 2002 direct medical costs as a result of fewer strokes. They also avoided an estimated $5.8 billion in 2002…  
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.